ESC Professional Premium Access

Natriuretic peptides, kidney function and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: pooled data from the I-PRESERVE, TOPCAT, PARAGON and DELIVER trials

Congress Presentation

About the speakers

Associate Professor Brendon Neuen

The George Institute for Global Health, Sydney (Australia)
0 follower

Doctor Peder Langeland Myhre

Akershus University Hospital - AHUS, Nordbyhagen (Norway)
4 presentations
0 follower

8 more presentations in this session

ESC Heart Failure Association age-adjusted natriuretic peptide thresholds for a new diagnosis of heart failure: diagnostic accuracy study

Speaker: Professor C. Taylor (Birmingham, GB)

Thumbnail

Screening for stage B heart failure in Type 2 diabetes: natriuretic peptide screening alone misses echocardiographic abnormalities

Speaker: Doctor C. Chandramouli (Singapore, SG)

Thumbnail

Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy

Speaker: Doctor P. Gouda (Edmonton, CA)

Thumbnail

Exploring heart failure prevalence and overlooked dimensions: a comprehensive NT Pro-BNP study in high-risk primary care patients

Speaker: Professor A. Celik (Mersin, TR)

Thumbnail

Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

Speaker: Doctor Y. Takigami (Sagamihara, JP)

Thumbnail

Access the full session

Diagnostic accuracy of natriuretic peptides

Speakers: Associate Professor B. Neuen, Doctor P. Myhre, Professor C. Taylor, Doctor C. Chandramouli, Doctor P. Gouda...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations